• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation.

作者信息

Innao Vanessa, Urso Salvatore, Insalaco Monica, Borraccino Albino, Consoli Ugo

机构信息

U.O.C di Ematologia, Azienda ospedaliera di rilievo nazionale e di alta specializzazione, ARNAS - Garibaldi di Catania, Catania, Italy.

U.O.C. di Nefrologia, Azienda ospedaliera di rilievo nazionale e di alta specializzazione, ARNAS - Garibaldi di Catania, Catania, Italy.

出版信息

Thromb Res. 2022 Feb;210:91-93. doi: 10.1016/j.thromres.2021.12.029. Epub 2022 Jan 4.

DOI:10.1016/j.thromres.2021.12.029
PMID:35033862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8723754/
Abstract
摘要

相似文献

1
Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation.在一名异基因造血干细胞移植后淋巴瘤已治愈的患者中，接种辉瑞 - 生物科技公司的抗COVID - 19疫苗后发生免疫性血栓性血小板减少性紫癜。
Thromb Res. 2022 Feb;210:91-93. doi: 10.1016/j.thromres.2021.12.029. Epub 2022 Jan 4.
2
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.伴有严重ADAMTS13缺乏的成人期血栓性微血管病（血栓性血小板减少性紫癜）的流行病学和病理生理学：法国全国血栓性微血管病登记处的横断面分析
Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.
3
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.首例与基于 mRNA 的抗 COVID-19 疫苗接种相关的新发免疫性血小板减少性紫癜（iTTP）发作。
J Thromb Haemost. 2021 Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5.
4
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study.mRNA COVID-19 疫苗接种后免疫介导的血栓性血小板减少性紫癜复发：一项前瞻性队列研究。
Haematologica. 2022 Nov 1;107(11):2661-2666. doi: 10.3324/haematol.2022.280702.
5
[Transplantation related ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: a case report and literature review].[血栓性血小板减少性紫癜中与移植相关的ADAMTS13缺乏症：一例报告及文献综述]
Zhonghua Xue Ye Xue Za Zhi. 2014 Jan;35(1):69-70. doi: 10.3760/cma.j.issn.0253-2727.2014.01.020.
6
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.儿童期和青少年期起病的获得性血栓性血小板减少性紫癜伴严重ADAMTS13缺乏症：法国全国血栓性微血管病登记处的一项队列研究
Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.
7
Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation.致命性血栓性血小板减少性紫癜作为异基因干细胞移植后的一种罕见并发症。
Ann Hematol. 2000 Sep;79(9):527-9. doi: 10.1007/s002770000187.
8
von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation.干细胞移植过程中的血管性血友病因子裂解蛋白酶（ADAMTS13）
Semin Thromb Hemost. 2006 Mar;32(2):98-104. doi: 10.1055/s-2006-939765.
9
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.孕期表现为免疫性血小板减少性紫癜的遗传性血栓性血小板减少性紫癜：一例报告
J Med Case Rep. 2018 Jan 22;12(1):15. doi: 10.1186/s13256-017-1545-3.
10
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.严重急性呼吸综合征冠状病毒2型疫苗接种与免疫性血栓性血小板减少性紫癜
Blood. 2022 Apr 21;139(16):2570-2573. doi: 10.1182/blood.2022015545.

引用本文的文献

1
A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination.血管损伤的系统评价：新冠疫苗接种后危急情况下瘀点、紫癜和瘀斑的综述
Health Sci Rep. 2025 Mar 12;8(3):e70503. doi: 10.1002/hsr2.70503. eCollection 2025 Mar.
2
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS).基于mRNA的新型冠状病毒2型疫苗（BNT162b2）接种后的血栓形成——是时候超越血小板减少综合征（TTS）相关血栓形成进行思考了。
Thromb Update. 2022 May;7:100104. doi: 10.1016/j.tru.2022.100104. Epub 2022 Apr 18.
3
COVID-19 and HSCT (Hematopoietic stem cell transplant).COVID-19 与 HSCT（造血干细胞移植）。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101399. doi: 10.1016/j.beha.2022.101399. Epub 2022 Oct 8.
4
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.灭活新冠疫苗接种后获得性血栓性血小板减少性紫癜：两例报告及文献综述
Vaccines (Basel). 2022 Jun 24;10(7):1012. doi: 10.3390/vaccines10071012.
5
Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis.新冠疫苗接种后的免疫介导不良事件与疫苗类型：一项系统评价与荟萃分析
Egypt J Intern Med. 2022;34(1):44. doi: 10.1186/s43162-022-00129-5. Epub 2022 May 19.
6
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.接种 COVID-19 疫苗后的血栓性血小板减少性紫癜（TTP）：已报告病例的系统评价。
Thromb Res. 2022 Jun;214:115-121. doi: 10.1016/j.thromres.2022.04.020. Epub 2022 May 2.

本文引用的文献

1
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.腺病毒载体新冠疫苗诱导的免疫性血栓性血小板减少症的相关认识。
Blood. 2021 Dec 2;138(22):2256-2268. doi: 10.1182/blood.2021013231.
2
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.接种辉瑞-生物科技公司新冠疫苗后发生的免疫介导性血栓性血小板减少性紫癜
Haematologica. 2022 Apr 1;107(4):1008-1010. doi: 10.3324/haematol.2021.279535.
3
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.获得性血栓性血小板减少性紫癜，可能与阿斯利康-牛津新冠疫苗有关。
EJHaem. 2021 May 18;2(3):534-536. doi: 10.1002/jha2.219. eCollection 2021 Aug.
4
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia.新型冠状病毒 2 型疫苗与血栓：疫苗诱导的免疫性血栓性血小板减少症的专家共识。
Thromb Haemost. 2021 Aug;121(8):982-991. doi: 10.1055/a-1499-0119. Epub 2021 May 4.
5
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.Ad26.COV2.S疫苗接种后血栓性血小板减少症
N Engl J Med. 2021 May 20;384(20):1964-1965. doi: 10.1056/NEJMc2105869. Epub 2021 Apr 14.
6
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
7
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.辉瑞和莫德纳新冠疫苗接种后出现的血小板减少症。
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
8
Rabies vaccine-associated thrombotic thrombocytopenic purpura.狂犬病疫苗相关血栓性血小板减少性紫癜
Transfus Med. 2014 Dec;24(6):428-9. doi: 10.1111/tme.12160. Epub 2014 Nov 10.
9
Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination.肺炎球菌疫苗接种后发生急性血栓性血小板减少性紫癜
Blood Coagul Fibrinolysis. 2014 Jul;25(5):512-4. doi: 10.1097/MBC.0000000000000058.
10
[Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination].[甲型H1N1流感疫苗接种后发生的极重型血栓性血小板减少性紫癜（TTP）]
Med Klin (Munich). 2010 Sep;105(9):663-8. doi: 10.1007/s00063-010-1107-6. Epub 2010 Sep 28.